Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
140 participants
INTERVENTIONAL
2001-07-31
2003-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
NCT00000310
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
NCT00000309
Evaluation of Benztropine for Cocaine Craving - 2
NCT00000333
Early Phase II Trials for Cocaine Medication Development - 1
NCT00000317
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reserpine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cincinnati VA Medical Center
OTHER_GOV
National Institute on Drug Abuse (NIDA)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NIDA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eugene Somoza, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Cincinnati VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Boston University Medical Center
Boston, Massachusetts, United States
Cincinnati VA Medical Center
Cincinnati, Ohio, United States
Dayton VA Medical Center
Dayton, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Winhusen TM, Lewis DF, Somoza EC, Horn P. Pharmacodynamics must inform statistics: an example from a cocaine dependence pharmacotherapy trial. ISRN Addict. 2014 Feb 5;2014:927290. doi: 10.1155/2014/927290. eCollection 2014.
Winhusen TM, Somoza EC, Lewis DF, Kropp F, Theobald J, Elkashef A. An Evaluation of Substance Abuse Treatment and HIV Education on Safe Sex Practices in Cocaine Dependent Individuals. ISRN Addict. 2014 Mar 4;2014:912863. doi: 10.1155/2014/912863. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTO-0001-1
Identifier Type: -
Identifier Source: org_study_id
NCT00024869
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.